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Abstract The crystal structure of human cycfin H has been 
solved at 2.6 A resolution by the MIR method and ref'med to an 
R-factor of 23.1%. The core of the molecule consists of two 
helical repeats adopting the canonical cyclin fold already 
observed in the structures of cyclin A [Brown et al. (1995) 
Structure 3, 1235-1247; Jeffrey et al. (1995) Nature 376, 313- 
320; Rosso et al. (1996) Nature 382, 325-331] and TFIIB 
INikoiiov et al. (1995) Nature 377, 119-128]. The N-terminal 
and C-terminal residues form a new domain built on two long 
helices interacting essentially with the first repeat of the 
molecule. 
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1. Introduction 
Cyclins are the positive regulatory subunits of cyclin-de- 
pendent kinases (CDK). They play a crucial role in the co- 
ordination of the eucaryotic ell cycle by binding to the cat- 
alytic subunits of CDKs [5,6]. They share distant sequence 
homology over a 100 amino acid region called the cyclin 
box and have been classified in two phylogenetically divergent 
subfamilies. The first contains A, B, D, E, F, G, ... cyclins and 
the second the C and H cyclins [7]. 
Cyclin A is so far the only cyclin whose 3-dimensional 
structure has been determined. A member of the first subfam- 
ily, it has been extensively studied in its free state [1], com- 
plexed with CDK2 [2] and in a ternary complex with CDK2 
and the inhibitor p27 Kipl [3]. These structures how that the 
cyclin box is associated with a structural domain of five he- 
lices repeated once in the structure. The same topology, now 
referred to as the cyclin fold, was later found in the structure 
of the general transcription factor TFI IB [4]. Upon the for- 
mation of the CDK2-cycl in A complex, cyclin A does not 
undergo significant conformational changes [1,2] whereas 
very large ones occur in CDK2 when compared to its free 
state [8]. 
No structural information has so far been available for the 
second subfamily composed of H and C cyclins. Human cy- 
clin H, a protein of 323 amino acids, is well conserved from 
yeast to human. It shares significant homologies with C-type 
cyclins [9,10]. However, only 23.1% identity and 43% similar- 
ity is observed with human cyclin A. Cyclin H was originally 
identified as a member of the Cyclin-dependent activating 
kinase complex, composed of cyclin H, CDK7 and MAT1 
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[11-15]. Further investigations revealed that cyclin H is also 
a subunit of the general transcription factor TFI IH,  a multi- 
protein complex involved in three important mechanisms, 
transcription, DNA repair and cell cycle regulation, contain- 
ing at least nine subunits and shown to possess several enzy- 
matic activities including helicase, ATPase and kinase [16-21]. 
As a first step towards structural investigation of TFI IH,  
we present here the crystal structure of human cyclin H de- 
termined at 2.6 A resolution by the multiple isomorphous 
replacement method. 
2. Materials and methods 
Recombinant human cyclin H was expressed in Escherichia coli and 
purified according to the protocol described in [22]. For crystallisation 
the protein was desalted into a solution containing 300 mM ammo- 
nium phosphate, 30 mM sodium citrate, 10 mM [3-ME at pH 5.8 and 
concentrated to 15-20 mg/ml in Centricon cells. Crystals were grown 
by vapour diffusion in hanging drops at 4°C by mixing equal volumes 
of the protein and of a reservoir solution containing 1 M ammonium 
phosphate, 0.1 M sodium citrate, 2% glycerol, 10 mM [3-ME at pH 
5.8. Brick-shaped crystals with maximum dimensions of 0.6 × 0.4 × 0.2 
mm 3 grew in 1-3 weeks. They. belong to the space group I4(1)22 with 
cell parameters a = b = 84.04 A and c = 373.3 A. The asymmetric unit 
contains one molecule of cyclin H and has a very high solvent content 
of 72%. 
In order to allow preparation of heavy atom derivatives and data 
collection at cryogenic temperature, crystals were transferred stepwise 
into a stabilising solution containing 1 M ammonium sulphate, 50 
mM MES, 10 mM [3-ME at pH 5.8. The quality of the diffraction 
pattern and the resolution limit of diffraction from stabilised crystals 
were similar to that obtained from crystals mounted in the mother 
liquor containing ammonium phosphate. Native (20-3.0 A) and deriv- 
ative data sets (12-3.5 A) were collected at 4°C to solve the structure. 
Data used for structure refinement were collected at a cryogenic tem- 
perature (Table 1). For this purpose, crystals were transferred stepwise 
to the stabilising solution containing in addition 32% v/v glycerol and 
then flash-frozen in a nitrogen stream at -160°C [23]. All data were 
integrated and scaled using the program XDS [24]. 
Heavy atom derivatives were obtained by soaking crystals in the 
stabilising solution (without [3-ME) containing 10 ~M of either HgBr2 
(16 h) or EtHgC1 (4 h). Two sites were detected for the HgBr 2 deriv- 
ative and one site for the EtHgCI derivative. Reflections between 12 
and 4.5 ,~. were phased to an overall figure of merit of 0.44, using 
programs from the CCP4 suite [25]. The phasing powers were 1.03 
and 1.26 for the HgBr2 and EtHgC1 derivative, respectively. In spite 
of the low value of the figure of merit, the quality of the MIR map 
calculated in the range 12~,.5 A allowed us to locate the molecule in 
the unit cell and to build long helices in the electron density with the 
modelling program 'O' [26]. Phases were extended to 3.5 A by solvent 
flattening with the program DM [27]. The resulting map enabled us to 
build most of the molecule. Several cycles of combination of MIR and 
model phases with SIGMAA [28] followed by density modification 
with DM were used to extend the phases to 3.0 A and improve the 
model. The data collected at cryogenic temperature were then used to 
carry on further model building and refinement. The final model was 
subjected to minimisation, simulated annealing/torsion angle dy- 
namics, B-factor refinement and bulk solvent correction with the 
package X-PLOR [29], and the resolution was gradually extended 
from 3.0 to 2.6 A. The final R-factor is 23.1% for 18836 reflections 
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66 G. Andersen et al./FEBS Letters 397 (1996) 65~9 
Fig. 1. Stereo view of the experimental 2Fo-F~ electron density map contoured at 1.7cJ after the final refinement of the cyclin H model at 2.6 A 
resolution. This region of the first domain shows a cluster of hydrophobic amino acids, rich in aromatic residues, located close to the centre of 
helix H3, characteristic of the cyclin box. 
larger than 2~, and the free R-factor is 29.0% (Table 1). The averalge 
B-factor of the model as given by the bulk solvent correction is 50 A 2 
except for two disordered loops (between amino acids 181-183 and 
234-243) where B-factors can exceed 100 ~2 This is in agreement 
with the overall B-factor determined by Wilson plot on the measured 
intensities. It can be explained by the high solvent content in the 
crystal and the few packing interactions between the molecules in 
the crystal lattice. The stereochemistry of the model was inspected 
with PROCHECK [30]. For the main chain dihedral angles, 83% of 
the residues were in the most favoured regions and 17% were in the 
additional allowed regions of the Ramachandran plot. The PRO- 
CHECK G-value was 0.0. 
3. Results and discussion 
The final model includes 277 amino acid residues and 45 
water molecules. The first 10 residues at the N-terminus and 
Table 1 
Statistics for data used in the structure determination 
the last 35 residues at the C-terminus (288-323), could not be 
built with confidence due to a probable disorder in the crys- 
tals. Fig. 1 shows a port ion of the final 2Fo-Fc electron den- 
sity map around a central helix of the model. It is of interest 
to note that limited proteolysis experiments performed with 
chymotrypsin generate a stable product with an approximate 
molecular weight of 31 kDa with the N-terminal starting at 
Ser 12 (our unpubl ished results). This proteolytic fragment cor- 
responds to what can be traced in the electron density map. 
As expected, the mercury sites are located close to Cys 57, 
Cys s4 and Cys 2s° in the refined structure. 
The structure of cyclin H (Fig. 2) comprises two a-helical 
domains which form two lobes linked by a short hinge region 
giving the molecule its elongated shape. A third essentially 
Number of Resolution Mean Rmerg e Data coverage Multiplicity Temperature Source and 
crystals (A) I/6(I) (%) (%) (°C) detector 
Native 1 1 20-3.8 16.1 4.4 91.5 2.4 4 Rot. anode 
(4.0-3.8) (5.1) (9.2) (62.7) (I .4) area detector 
Native 2 2 12-3 25.2 5.4 95.3 2.6 4 LURE W32 
(3.2-3.0) (6.5) (22.8) (95.9) (2.7) MAR IP 
HgBr2 2 12-3.5 26.8 6.1 94.3 3.2 4 LURE W32 
(4-3.5) (13.3) (13.2) (95.9) (3.0) MAR IP 
EtHgC1 2 12-3.5 32.1 7.5 82,9 4.0 4 LURE W32 
(4--3.5) (17.9) (15.9) (85.7) (4.1) MAR IP 
Cryo I 1 14-3.1 21.2 6.3 93,3 3.5 --154 Rot. anode 
(3.5-3.1) (7.6) (18.9) (94.6) (3.5) MAR IP 
Cryo 2 1 10-2.6 23.2 5.9 91.5 2.8 -160 LURE W32 
(2.7-2.6) (4.5) (28.6) (95.0) (2.6) MAR IP 
r .m,s  
Refine- Resolution Reflections Number of non- Number of Rconv/Rfr~ Bonds Angles 
ment (,~) (with I F I > 2~) hydrogen atoms waters (%) (,~) (°) 
14-2.6 18836 2288 45 23.1/29.1 0.017 2.07 
In the resolution range 14-2.6 ~, there are 21 133 possible unique reflections. From a total of 20809 measured reflections at 14-2.6 ,~ 1575 
reflections were selected for the test set. The values in parentheses are for the outer resolution shell. Abbreviations: 
Rmerge = (EhEj=I,N IIh--Ih(j) l)PZN × Ih for the intensity of reflection h observed N times, r.m.s. = root-mean-square deviations from ideal geometry, 
Rconv = Eh II Fo l -- I Fc II/Eh I Fo I where [ Fe I is the calculated structure factor scaled to Fo, Rfr~ is identical to Rconv on a subset of test reflections not 
used in refinement. 






Fig. 2. The fold of human cyclin H. (A) Schematic diagram of human cyclin H using the program SETOR [32]. The secondary structures, he- 
lices represented ascylinders and random coil stretches of the protein, were defined using the program DSSP [33]. The first two compact do- 
mains (blue) share the common cyclin fold already observed in the structure of cyclin A [1,2]. They are built of five helices identified as H1 to 
H5 for the first repeat and HI' to H5' for the second. The long helix H5 kinks at Glu 145 into two helices, H5~ and H5[~. HN (magenta) nd 
HC (pink) designate he N-terminal and C-terminal helices which form a third domain characteristic of cyclin H. The view suggests he exist- 
ence of a pseudo-two f ld axis superposing the two helical domains. (B) Stereo view of the molecule using the same orientation with the num- 
bering of the amino acids. 
helical (helices HN and HC) domain associates the N- and C- 
terminal regions of the protein. The overall dimensions of the 
molecule are roughly 65×40×40 A. Only a few residues 
adopt a conformation characteristic of 15-strands but no I]- 
sheets are present in the structure. Hence the structure agrees 
with CD data which predicted a mostly a-helical protein [22]. 
The first two domains consist of five helices each (H1-H5 
and HI ' -H5') .  Both exhibit he cyclin fold topology, a topol- 
ogy also found in cyclin A and TFIIB [2,4]. The central helix 
H3 (H3' in the second repeat) plays a key role in the organi- 
sation of the structure. On one side H3 (H3') is flanked by 
helices H1 and H2 (HI' and H2') located at the interface 
between the two lobes of the molecule. Towards the outside 
of the repeat H3 (H3') contacts helices H4 and H5 (H4' and 
H5'). All these helices pack through clusters of hydrophobic 
residues conserved in sequences of all cyclin H. The structures 
of cyclin A, free [1] or complexed with CDK2 [2] as well as 
sequence alignments [7,31] have suggested the high conserva- 
tion of the 'cyclin box' domain observed in all cyclins. This 
100 amino acid region essentially corresponds to the first he- 
lical repeat (H1-H5). The structure of cyclin H allows its 
extension to more distantly related members of the subfamily 
including cyclin C [7]. 
Superposition of cyclin H and cyclin A illustrates the struc- 
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Fig. 3. Superposition f free human cyclin H and bovine cyclin A [1], with the helical repeats coloured blue and green, respectively. The back- 
bone atoms of both cyclins are represented schematically using the program SETOR [32]: The molecules are superimposed using helices HI, 
H2 and H3 of the first repeat. The two repeats uperimpose with a r.m.s, deviation of 1.2 A (for 48 Ca atoms). If helices H1 to H3 of the two 
repeats overlap well, helices H4, H5, H4' and H5' are moved and differently oriented in the two structures. The N- and C-terminal helices of 
cyclin H and cyclin A are respectively labelled H:HN (magenta), H:HC (pink) and A:HN (red) and A:HC (yellow). Their locations are char- 
acteristic of the two cyclins, one essentially close to the first repeat (cyclin H), the other at the interface between the two repeats (cyclin A). 
tural similarity of the two repeats in both structures (Fig. 3). 
The three helices HI, H2 and H3 from the core of the first 
module of cyclin H superimpose with a root-mean-square 
(r.m.s.) value of 1.2 A for 48 Ca atoms on the corresponding 
helices of cyclin A. However, significant differences can be 
observed between the two cyclins. Helices H1 and H5 are 
respectively one turn and two turns longer at their N-terminal 
ends in cyclin H than in cyclin A. A kink in helix H5 occurs at 
Glu 145 in the middle of the helix. It is stabilised by two water 
molecules o that the helix segments forms an angle of ap- 
proximately 30 ° . 
Two extended structures located between helices H5 and 
HI '  and H5' and HC, form a hinge holding the two lobes 
of the molecule. A set of interactions, including salt bridges, 
involving amino acids from the hinge, the two first helices of 
each lobe (HI, H2, HI '  and H2') as well as water molecules, 
imposes the relative positioning of the two lobes. This orien- 
tation is different from that observed in TFIIB and similar to 
that in cyclin A despite a different set of interactions in the 
interface region of this molecule. 
The third domain, specific to cyclin H, is essentially in con- 
tact with the first repeat and the hinge region. It is built of 
two long helices, HN and HC and the connecting loop 
from HN to H1. Helix HN packs with one side of H1 and 
its N-terminus points into the cleft between the two repeats. 
Helix HC sits on the other side of H1 and contacts the 
loop connecting helices H2 and H3. This domain plays a 
major role in the structural integrity of cyclin H and dis- 
tinguishes it from cyclin A. It is located on the side opposite 
to the kinase recognition surface as seen in the cyclin A/ 
CDK2 complex [2]. In cyclin A, the N- and the C-terminal 
ends are separated and fill two clefts between the repeats (Fig. 
3). This gives to cyclin A a more compact shape compared to 
cyclin H. 
The regions of cyclin A containing the amino acids shown 
to interact with the kinase in the structure of the complex [2], 
superpose almost perfectly on the structure of cyclin H. Most 
of these are highly conserved within the cyclin families. The 
similar location of these residues implies that the CDK2-cy- 
clin A structure provides a good model for most if not all 
CDK-cyclin pairs. The interface between CDK2 and cyclin 
A, which involves residues from the first repeat and the linker 
to the second [2], is likely to be similar in all complexes. The 
residues Tyr 185 and Ile 182 in the N-terminal helix of cyclin A 
are also involved in kinase recognition [2]. In the structure of 
cyclin H there are no equivalent residues. However, it is pos- 
sible that the 10 N-terminal residues, which cannot be traced, 
play an analogous role in the cyclin H-CDK7 complex since 
the Ca atom of Trp 11 is within 3 ,~ of the Ca atom of Lys 192 
of cyclin A when the two structures are superposed. 
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Coordinates have been deposited at the Brookhaven Pro- 
tein Data Bank. 
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